BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 31298376)

  • 21. Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR.
    He RQ; Cen WL; Cen JM; Cen WN; Li JY; Li MW; Gan TQ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 46(3):925-952. PubMed ID: 29669324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
    Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
    J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer.
    Xu X; Zhu S; Tao Z; Ye S
    Cancer Med; 2018 Jan; 7(1):21-31. PubMed ID: 29266846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum microRNA-135a as a diagnostic biomarker in non-small cell lung cancer.
    Zou Y; Jing C; Liu L; Wang T
    Medicine (Baltimore); 2019 Dec; 98(50):e17814. PubMed ID: 31852062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer.
    Liu F; Li T; Hu P; Dai L
    Dis Markers; 2021; 2021():8819934. PubMed ID: 33763157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical impact of serum miR-661 in diagnosis and prognosis of non-small cell lung cancer.
    Zhou GH; Yang WH; Sun B
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5696-5701. PubMed ID: 29272005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
    Chen SW; Wang TB; Tian YH; Zheng YG
    Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer.
    Chu G; Zhang J; Chen X
    J Drug Target; 2016 Aug; 24(7):613-7. PubMed ID: 26581116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy.
    Cui EH; Li HJ; Hua F; Wang B; Mao W; Feng XR; Li JY; Wang X
    Acta Pharmacol Sin; 2013 Feb; 34(2):309-13. PubMed ID: 22983388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
    Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M
    Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
    Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
    Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis.
    Yuxia M; Zhennan T; Wei Z
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):2045-50. PubMed ID: 22806310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.
    Dong X; Chang M; Song X; Ding S; Xie L; Song X
    Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
    Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A
    Microrna; 2019; 8(3):206-215. PubMed ID: 30652656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
    Trakunram K; Chaniad P; Geater SL; Keeratichananont W; Chittithavorn V; Uttayamakul S; Buya S; Raungrut P; Thongsuksai P
    Cancer Biol Med; 2020 Aug; 17(3):652-663. PubMed ID: 32944397
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
    Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.